Rozalina Mccoy is an Endocrinologist in Baltimore, Maryland. Dr. Mccoy has been practicing medicine for over 17 years and is rated as an Elite provider by MediFind in the treatment of Low Blood Sugar. Her top areas of expertise are Low Blood Sugar, Type 2 Diabetes (T2D), Maturity Onset Diabetes of the Young, and Diabetic Hyperglycemic Hyperosmolar Syndrome.

Peter Cheng is a primary care provider, practicing in Internal Medicine in Columbia, Maryland. Dr. Cheng is rated as an Experienced provider by MediFind in the treatment of Low Blood Sugar. His top areas of expertise are Hypertension, Glucocorticoid-Remediable Aldosteronism, Familial Hypertension, and Mediastinal Tumor.

Dr. Mathioudakis, an endocrinologist and researcher, has a strong focus on diabetes management and patient care, recognized through awards like the Baltimore Top Doc. He has contributed significantly to diabetes research, authoring over 150 publications and participating in the development of consensus guidelines in the field. His studies have offered valuable insights into using health informatics for diabetes prevention and management. After graduating from the Johns Hopkins University School of Medicine and completing his training in Internal Medicine and a fellowship in Endocrinology, Diabetes, & Metabolism, Dr. Mathioudakis joined the faculty in the Division of Endocrinology, Diabetes & Metabolism in 2012. He earned a Master of Health Science in clinical investigation in 2015 and was the Clinical Director of the Division of Endocrinology from 2016 to 2021. Currently, he co-directs the Baltimore Metropolitan Diabetes Regional Partnership, focusing on improving access to diabetes prevention and management programs. As a physician-scientist, Dr. Mathioudakis leads multiple research studies funded by the NIH, private philanthropic organizations (Helmsley Charitable Trust), non-profit organizations (Breakthrough T1D), and industry. His research focuses on the effectiveness of automated diabetes prevention programs and strategies to reduce racial disparities in diabetes technology access. He also collaborates nationally to enhance care for people with type 1 diabetes. Holding a joint appointment in the Division of Biomedical Informatics and Data Science, Dr. Mathioudakis integrates machine learning and AI in diabetes research. He has served on the national Epic Endocrinology Specialty Steering Board and chaired the Type 2 Diabetes Prognostics Working Group for the Precision Medicine Diabetes Initiative. Committed to education, he frequently lectures on endocrinology, epidemiology, and health informatics. Dr. Mathioudakis is rated as a Distinguished provider by MediFind in the treatment of Low Blood Sugar. His top areas of expertise are Type 2 Diabetes (T2D), Type 1 Diabetes (T1D), Low Blood Sugar, Maturity Onset Diabetes of the Young, and Pancreaticoduodenectomy.

Cheryl Leonardi is a primary care provider, practicing in Internal Medicine in Ellicott City, Maryland. Dr. Leonardi is rated as an Advanced provider by MediFind in the treatment of Low Blood Sugar. Her top areas of expertise are Hypertensive Heart Disease, Enlarged Liver, Anemia, and Pediatric Myocarditis. Dr. Leonardi is currently accepting new patients.

Javzandulam Natsag is an Endocrinologist in Columbia, Maryland. Dr. Natsag is rated as an Experienced provider by MediFind in the treatment of Low Blood Sugar. Her top areas of expertise are Graves Disease, Thyroid Storm, Maturity Onset Diabetes of the Young, and Familial Hypocalciuric Hypercalcemia Type 1.

Sergio Lizama is an Endocrinologist in Columbia, Maryland. Dr. Lizama is rated as an Experienced provider by MediFind in the treatment of Low Blood Sugar. His top areas of expertise are Idiopathic Hypercalciuria, Hypercalcemia, Milk-Alkali Syndrome, and Familial Hypocalciuric Hypercalcemia Type 1.

Suzan Abdo is a primary care provider, a Geriatrics specialist and a General Practice provider in Columbia, Maryland. Dr. Abdo is rated as an Experienced provider by MediFind in the treatment of Low Blood Sugar. Her top areas of expertise are Familial Hypercholesterolemia, Homozygous Familial Hypercholesterolemia (HoFH), Hyperlipoproteinemia Type 4, and Defective Apolipoprotein B-100. Dr. Abdo is currently accepting new patients.

Warren Ross is a primary care provider, practicing in Internal Medicine in Ellicott City, Maryland. Dr. Ross is rated as an Experienced provider by MediFind in the treatment of Low Blood Sugar. His top areas of expertise are Cerebellar Degeneration, Inborn Amino Acid Metabolism Disorder, Anemia, and High Cholesterol. Dr. Ross is currently accepting new patients.

Javier Quant-Gonzalez is a primary care provider, practicing in Internal Medicine in Columbia, Maryland. Dr. Quant-Gonzalez is rated as an Experienced provider by MediFind in the treatment of Low Blood Sugar. His top areas of expertise are Cellulitis, Hypothyroidism, Obesity in Children, and Dementia.

Mahfuzul Khan is an Endocrinologist in Ellicott City, Maryland. Dr. Khan is rated as an Experienced provider by MediFind in the treatment of Low Blood Sugar. His top areas of expertise are Type 2 Diabetes (T2D), Maturity Onset Diabetes of the Young, Hyperthyroidism, and Thyroid Storm.

Rupal Desai is a primary care provider, practicing in Neurologist in Ellicott City, Maryland. Dr. Desai is rated as an Experienced provider by MediFind in the treatment of Low Blood Sugar. Her top areas of expertise are Inborn Amino Acid Metabolism Disorder, Wiskott-Aldrich Syndrome, Anemia, and High Cholesterol.

Diane Kepner is a primary care provider, practicing in Family Medicine in Ellicott City, Maryland. Dr. Kepner is rated as an Experienced provider by MediFind in the treatment of Low Blood Sugar. Her top areas of expertise are Glucocorticoid-Remediable Aldosteronism, Hypertension, Familial Hypertension, and Infant Hyperglycemia.

Todd T. Brown, MD, PhD is a clinical investigator who focuses on body composition, metabolic, and skeletal abnormalities observed in people with HIV, particularly as related to aging. Through translational investigation, epidemiologic studies, and clinical trials, he has been interested in understanding the pathogenesis of glucose disorders, fat changes, hormonal dysregulation, and osteoporosis in people with HIV, the consequences of these conditions (eg cardiovascular disease, frailty), and their optimal evaluation and management. Dr. Brown is rated as an Advanced provider by MediFind in the treatment of Low Blood Sugar. His top areas of expertise are Low Blood Sugar, Osteoporosis, Malnutrition, Gastric Bypass, and Gastrostomy.

David Levitt is an Endocrinologist in Hanover, Maryland. Dr. Levitt is rated as an Advanced provider by MediFind in the treatment of Low Blood Sugar. His top areas of expertise are Type 1 Diabetes (T1D), Type 2 Diabetes (T2D), Hypothyroidism, and Hyperthyroidism.

Ayana Seibles is a Vascular Surgeon in Laurel, Maryland. Dr. Seibles is rated as an Experienced provider by MediFind in the treatment of Low Blood Sugar. Her top areas of expertise are Lung Metastases, Familial Neurocardiogenic Syncope, Vertigo, and Headache.

Dr. Jodi Segal is a professor of medicine at the Johns Hopkins University School of Medicine. She has joint appointments in health policy and management, and epidemiology at the Johns Hopkins Bloomberg School of Public Health. Dr. Segal is internationally recognized as a clinician-investigator in comparative effectiveness research and pharmacoepidemiology. She trains investigators to conduct research to advance Johns Hopkins Medicine as a learning health system. She serves as the associate director of the Center for Health Services and Outcomes Research (CHSOR) and the co-director of the Center for Drug Safety and Effectiveness (CDSE), both in the School of Public Health. Dr. Segal received a B.S. from The Pennsylvania State University. She earned her M.D. from the University of Pittsburgh School of Medicine and her M.P.H. from the Johns Hopkins Bloomberg School of Public Health. She completed her residency at the University of Chicago and a fellowship in general nternal medicine at Johns Hopkins. She is a member of Phi Beta Kappa and Alpha Omega Alpha. Dr. Segal is rated as an Experienced provider by MediFind in the treatment of Low Blood Sugar. Her top areas of expertise are Giant Papillary Conjunctivitis, Type 2 Diabetes (T2D), Vernal Keratoconjunctivitis, and Allergic Conjunctivitis.

Dr. Rita Kalyani is a Professor of Medicine at Johns Hopkins School of Medicine. She graduated with an undergraduate degree from Harvard College and completed her medical degree, residency, and fellowship at Johns Hopkins. She also obtained a Masters in Health Science degree in Clinical Investigation from the Johns Hopkins Bloomberg School of Public Health. As a NIH-funded clinician scientist, Dr. Kalyani has authored over 175 peer-reviewed publications and built a research program focused on understanding the factors leading to development of diabetes complications, particularly in high-risk populations. She has conducted epidemiological and patient-oriented research that has led to fundamental discoveries regarding the development of skeletal muscle loss, physical disability, and frailty in diabetes. She has also spearheaded studies investigating sex differences in cardiovascular disease and diabetes which have influenced primary prevention guidelines. Dr. Kalyani launched the Diabetes Management Service for Johns Hopkins’ Total Pancreatectomy Islet Auto Transplant Program in 2011. She is the co-founder of the Johns Hopkins Diabetes POC-IT Guide for healthcare professionals. She is also the founder and past Editor-in-Chief of the Johns Hopkins Patient Website to Diabetes. Dr. Kalyani has been the Chief Scientific and Medical Officer of the American Diabetes Association since 2025. She previously served as President of Medicine & Science on the ADA's National Board of Directors. She continues to have a clinical practice as an adult endocrinologist. Dr. Kalyani is rated as an Experienced provider by MediFind in the treatment of Low Blood Sugar. Her top areas of expertise are Seasonal Affective Disorder (SAD), Type 2 Diabetes (T2D), Maturity Onset Diabetes of the Young, Pancreatectomy, and Islet Cell Transplantation.

Dr. Donner's clinical and research interests have focused on the prevention of complications in patients with type 1 and 2 diabetes. For 6 years, he was the Associate Medical Director of the Joslin Diabetes Center affiliate at the University of Maryland, and then Medical Director from 2004 - 2010. After joining the faculty at Johns Hopkins University in 2010, his clinical and research interests became fully dedicated to diabetes. He became the Director of The Johns Hopkins Diabetes Center in 2011. He has been a clinical investigator in a number of NIH- and industry-funded diabetes research trials. Dr. Donner was a co-PI in the NIH-funded Veterans Affairs Implantable Insulin Pump Study, a Co-PI on the NIDDK-funded Diabetes Control and Complications Trial / Epidemiology of Diabetes Intervention and Complications (DCCT / EDIC) Study for 16 years, and Co-PI for the Bypass Angioplasty Revascularization Investigation 2 Diabetes (BARI 2D) for 7 years. Recently, he has served as PI for the Durable-response therapy Evaluation For Early or New-onset type 1 Diabetes (DEFEND-1). Dr. Donner is currently collaborating with Dr. Abdel Hamad in Immunology on preventing B-regulatory cell apoptosis using a novel monoclonal antibody targeting the presumptive apoptotic factor. This antibody prevents the development of type 1 diabetes in non obese diabetic mice. Dr. Donner is the PI for Johns Hopkins for TrialNet, a multicenter, international consortium of investigators studying ways to prevent Type 1 diabetes and preserve insulin secretion in individuals with newly diagnosed Type 1 diabetes. He is also a PI for a study investigating FIAsp, a faster-acting insulin aspart in subjects with type 1 diabetes, and is working with investigators at the Johns Hopkins School of Engineering on an implantable insulin pump which delivers insulin intravenously. Dr. Donner is rated as an Experienced provider by MediFind in the treatment of Low Blood Sugar. His top areas of expertise are Type 1 Diabetes (T1D), Diabetic Nephropathy, Type 2 Diabetes (T2D), and Maturity Onset Diabetes of the Young.

Talia Hitt is an assistant professor of pediatrics in the Division of Pediatric Endocrinology at the Johns Hopkins University School of Medicine. Her clinical practice focuses on all endocrine issues, with a particular focus in pediatric diabetes, insulin resistance and obesity. Dr. Hitt received her undergraduate degree from Colby College, after which she performed research in genetics at the Children’s Hospital of Boston. Dr. Hitt then attended the University of Connecticut School of Medicine, where she obtained a dual M.D./M.P.H. (Master of Public Health) degree. She completed her pediatric residency at the Children’s Hospital of Philadelphia, followed by a fellowship in pediatric endocrinology at the Children’s Hospital of Philadelphia. During her fellowship, Dr. Hitt was awarded a prestigious grant from the Pediatric Endocrine Society to support her research in type 2 diabetes. Dr. Hitt also received a second clinical research master’s degree (Master of Science in Health Policy Research) from the University of Pennsylvania during her fellowship. Dr. Hitt’s research focus is on pediatric type 2 diabetes: its development, progression and innovative therapies. She is studying the relationship between insufficient sleep and type 2 diabetes in adolescents. In 2021, Dr. Hitt was awarded a supplemental award to a 2018 National Institute of Diabetes and Digestive and Kidney Diseases R01 award studying cardiometabolic risk among South Asian adolescents compared with African American and white peers. Dr. Hitt has additionally studied the clinical implementation of new therapeutics in pediatric diabetes care. Dr. Hitt is affiliated with the Pediatric Endocrine Society, the Endocrine Society, and the American Diabetes Association. Dr. Hitt is rated as an Experienced provider by MediFind in the treatment of Low Blood Sugar. Her top areas of expertise are Type 1 Diabetes (T1D), Short Stature (Growth Disorders), Type 2 Diabetes (T2D), and Low Blood Sugar.

Ravi Passi is a primary care provider, practicing in Internal Medicine in Cantonsville, Maryland. Dr. Passi is rated as an Experienced provider by MediFind in the treatment of Low Blood Sugar. His top areas of expertise are Hypothyroidism, Obesity in Children, Hypertension, and Familial Hypertension. Dr. Passi is currently accepting new patients.